Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00962949 · ClinicalTrials.gov registry record · Phase 1
The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
A Phase 1 study of Postural Orthostatic Tachycardia Syndrome (POTS), sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT00962949: Completed Phase 1 study of Postural Orthostatic Tachycardia Syndrome (POTS), sponsored by Vanderbilt University Medical Center.
NCT00962949 is a Phase 1 study of Postural Orthostatic Tachycardia Syndrome (POTS) that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 28 participants, below the 103-participant average among 4 other Postural Orthostatic Tachycardia Syndrome (POTS) trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00962949, a Phase 1 study of Postural Orthostatic Tachycardia Syndrome (POTS), has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the role of the renin-angiotensin-aldosterone in the pathophysiology of postural tachycardia syndrome, and to provide an insight about the disease process in this disorder.
Primary Outcome
Change in MAP from baseline to after 1h of infusion.
Conditions Studied
Interventions
- DRUG Angiotensin II
Study Locations (1)
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
What the finished NCT00962949 record still lists
NCT00962949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 103-participant average among 4 other Postural Orthostatic Tachycardia Syndrome (POTS) trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Postural Orthostatic Tachycardia Syndrome (POTS) appearing as the primary indexed condition, and to 1 intervention - of which Angiotensin II is the first listed.
NCT00962949 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00962949 about?
NCT00962949 is a clinical study titled "The Renin-Aldosterone Axis in Postural Tachycardia Syndrome". The purpose of this study is to determine the role of the renin-angiotensin-aldosterone in the pathophysiology of postural tachycardia syndrome, and to provide an insight about the disease process in this disorder.
What is the current status of trial NCT00962949?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2009-04. Estimated completion is 2012-12.
What conditions does trial NCT00962949 study?
This clinical trial studies the following conditions: Postural Orthostatic Tachycardia Syndrome (POTS).
What interventions are being tested in trial NCT00962949?
The interventions under investigation include: Angiotensin II (DRUG).
Who is sponsoring clinical trial NCT00962949?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00962949 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Orthostatic Tachycardia Syndrome (POTS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
RECRUITING · Phase 2
-
Programming Aquatic Therapy for POTS
RECRUITING · NA
-
Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project
ACTIVE NOT RECRUITING
-
Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia